Bio-IT World November 14, 2024
Deborah Borfitz

Investigators at Weill Cornell Medicine have combined several powerful technologies to reconstruct how cancer spreads from the prostate to metastatic sites elsewhere in the body. Bioluminescence imaging, CRISPR/Cas9-based barcoding, and innovative computational methods for tracing the movement of cancer from tissue to tissue were used in creating a roadmap revealing the small number of aggressive cells that seed cancer’s often deadly migration.

A shared interest in evolutionary biology brought the research team together with colleagues at Cold Spring Harbor Laboratory to trace the trajectory of clonal populations of cancer cells from the primary tumor to metastatic sites such as the liver or bone. Their mission was to learn what special evolutionary adaptations permitted them to make the journey,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Provider
Cofactor AI Nabs $4M to Combat Hospital Claim Denials with AI
Shifting Our Healthcare Delivery Model from Reactive to Proactive
Trinity Health back in the black in Q1
109 hospitals receiving new Medicare-backed residency slots
Mayo develops new AI tools

Share This Article